Literature DB >> 31307927

Scales and mechanisms of somatic mutation rate variation across the human genome.

Fran Supek1, Ben Lehner2.   

Abstract

Cancer genome sequencing has revealed that somatic mutation rates vary substantially across the human genome and at scales from megabase-sized domains to individual nucleotides. Here we review recent work that has both revealed the major mutation biases that operate across the genome and the molecular mechanisms that cause them. The default mutation rate landscape in mammalian genomes results in active genes having low mutation rates because of a combination of factors that increase DNA repair: early DNA replication, transcription, active chromatin modifications and accessible chromatin. Therefore, either an increase in the global mutation rate or a redistribution of mutations from inactive to active DNA can increase the rate at which consequential mutations are acquired in active genes. Several environmental carcinogens and intrinsic mechanisms operating in tumor cells likely cause cancer by this second mechanism: by specifically increasing the mutation rate in active regions of the genome.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chromatin; DNA mismatch repair; Genomic instability; Mutation rates; Somatic cells; Tumors

Mesh:

Substances:

Year:  2019        PMID: 31307927     DOI: 10.1016/j.dnarep.2019.102647

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  18 in total

Review 1.  Histone Acetyltransferase MOF Orchestrates Outcomes at the Crossroad of Oncogenesis, DNA Damage Response, Proliferation, and Stem Cell Development.

Authors:  Mayank Singh; Albino Bacolla; Shilpi Chaudhary; Clayton R Hunt; Shruti Pandita; Ravi Chauhan; Ashna Gupta; John A Tainer; Tej K Pandita
Journal:  Mol Cell Biol       Date:  2020-08-28       Impact factor: 4.272

Review 2.  On the wrong DNA track: Molecular mechanisms of repeat-mediated genome instability.

Authors:  Alexandra N Khristich; Sergei M Mirkin
Journal:  J Biol Chem       Date:  2020-02-14       Impact factor: 5.157

3.  Genome-wide mapping of somatic mutation rates uncovers drivers of cancer.

Authors:  Maxwell A Sherman; Adam U Yaari; Oliver Priebe; Felix Dietlein; Po-Ru Loh; Bonnie Berger
Journal:  Nat Biotechnol       Date:  2022-06-20       Impact factor: 68.164

4.  The impact of rare germline variants on human somatic mutation processes.

Authors:  Mischan Vali-Pour; Ben Lehner; Fran Supek
Journal:  Nat Commun       Date:  2022-06-28       Impact factor: 17.694

Review 5.  A compendium of mutational cancer driver genes.

Authors:  Francisco Martínez-Jiménez; Ferran Muiños; Inés Sentís; Jordi Deu-Pons; Iker Reyes-Salazar; Claudia Arnedo-Pac; Loris Mularoni; Oriol Pich; Jose Bonet; Hanna Kranas; Abel Gonzalez-Perez; Nuria Lopez-Bigas
Journal:  Nat Rev Cancer       Date:  2020-08-10       Impact factor: 60.716

Review 6.  Non-coding driver mutations in human cancer.

Authors:  Kerryn Elliott; Erik Larsson
Journal:  Nat Rev Cancer       Date:  2021-07-06       Impact factor: 60.716

7.  Extreme differences between human germline and tumor mutation densities are driven by ancestral human-specific deviations.

Authors:  José María Heredia-Genestar; Tomàs Marquès-Bonet; David Juan; Arcadi Navarro
Journal:  Nat Commun       Date:  2020-05-19       Impact factor: 14.919

8.  Variable interplay of UV-induced DNA damage and repair at transcription factor binding sites.

Authors:  Joan Frigola; Radhakrishnan Sabarinathan; Abel Gonzalez-Perez; Nuria Lopez-Bigas
Journal:  Nucleic Acids Res       Date:  2021-01-25       Impact factor: 16.971

9.  Functional and genetic determinants of mutation rate variability in regulatory elements of cancer genomes.

Authors:  Christian A Lee; Diala Abd-Rabbo; Jüri Reimand
Journal:  Genome Biol       Date:  2021-05-03       Impact factor: 13.583

10.  DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers.

Authors:  David Mas-Ponte; Fran Supek
Journal:  Nat Genet       Date:  2020-08-03       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.